In recent years, alternative reinsurance capital has become more issuer-friendly with a series of innovations that have reduced costs, broadened coverage and introduced more efficient and flexible products. Niraj Patel, ILS Portfolio Manager, sets out the ways in which alternative capital is adapting to meet the ever-evolving needs of the insurance industry. In this paper he illustrates how alternative capital has become an integral part of many insurers’ risk-transfer strategy.
Read the full paper here.
What key points were uncovered in our recent survey of the health insurance market in the UAE?
The application of genetic data is redefining medical diagnosis, treatment and prognosis – and is set to adjust, maybe even to reshape, healthcare.